Latest News and Press Releases
Want to stay updated on the latest news?
-
ROCKVILLE, Md. and SUZHOU, China, March 17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company...
-
Saphnelo Surpasses Benlysta in CLE as Physicians Expand Use of Biologics Ahead of Key 2027 Catalysts
Exton, PA, March 17, 2026 (GLOBE NEWSWIRE) -- As treatment strategies evolve in cutaneous lupus erythematosus (CLE), physicians are increasingly turning to advanced systemic therapies while...
-
San Mateo, California, March 17, 2026 (GLOBE NEWSWIRE) -- SnapLogic, the Agentic Integration Company, today announced that Mind, the UK’s leading mental health charity, is using SnapLogic’s Agentic...
-
News Summary: NVIDIA Dynamo 1.0 provides a production-grade, open source foundation for inference at scale.Dynamo and NVIDIA TensorRT-LLM optimizations integrate natively into open source frameworks...
-
Phase 2 monotherapy trial of FG-3246, a potential first-in-class antibody drug conjugate (ADC) targeting CD46, in metastatic castration-resistant prostate cancer (mCRPC) is actively enrolling and...
-
New York, USA, March 16, 2026 (GLOBE NEWSWIRE) -- Pseudomonal Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling...
-
Austin, March 16, 2026 (GLOBE NEWSWIRE) -- Ticagrelor Market Size & Growth Analysis: "According to SNS Insider, The Ticagrelor Market was valued at USD 1.80 Billion in 2025 and is projected to...
-
Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Tezspire Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Saphnelo Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
Claret Capital Partners, Europe's largest independent growth debt fund manager has made an investment, through its Fund IV, of up to EUR 28m